Source comparison
Hexarelin Dosage Protocol Guide: Comparison Table
Research protocols vary significantly based on study duration, desired GH pulse pattern, and acceptable desensitization risk. The table below compares the three most common hexarelin dosing frameworks used in published endocrinology research. | Protocol Type |
This comparison does not assign a generated winner or score.
- Research protocols vary significantly based on study duration, desired GH pulse pattern, and acceptable desensitization risk. The table below compares the three most common hexarelin dosing frameworks used in published endocrinology research.
- | Protocol Type | Dose per Injection | Frequency | Duration | Primary Use Case | Desensitization Risk | Professional Assessment ||—|—|—|—|—|—|| Acute Single-Dose | 100–300mcg | Once (single administration) | 1 day | Receptor sensitivity testing, pharmacokinetic studies, GH reserve assessment | Minimal (no repeated exposure) | Ideal for establishing baseline GH responsiveness or comparing hexarelin potency to other secretagogues. Not suitable for studies requiring sustained GH elevation || Twice-Daily Maintenance | 100–150mcg | 2× daily (8–12 hour intervals) | 2–8 weeks | IGF-1 upregulation studies, body composition research, sustained GH elevation protocols | Moderate (manageable with 5-on-2-off cycling) | Balances efficacy and sustainability. Most versatile framework for intermediate-duration studies where consistent GH output matters more than peak amplitude || Intensive Pulsatile | 100–200mcg | 3× daily (4–6 hour intervals) | 7–14 days maximum | Maximal GH output studies, short-term